-
Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy
in Uncategorized onFerring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first…
0 -
Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET
in Uncategorized onFerring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET)…
-
Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers
in Uncategorized onFerring Pharmaceuticals announced today the appointment of Pascal Danglas, MD as Executive Vice President and Chief Medical Officer…
-
Ferring Pharmaceuticals Announces Grand Opening of U.S. Operations Center
in Uncategorized onFerring Pharmaceuticals has expanded its footprint in New Jersey with the opening of its new U.S. Operations Center on a 25-acre lot located at 100…
-
New data from a pooled analysis shows improved overall survival for prostate cancer patients treated with FIRMAGON® (degarelix) compared to LHRH agonists
in Uncategorized onNew data published in the December issue of the European Journal of Urology indicates improvement in overall survival (OS)…
-
CORTIMENT®MMX®, a new treatment for ulcerative colitis, receives European approval
in Uncategorized onFerring Pharmaceuticals announced today that its CORTIMENT® MMX® (budesonide) treatment for the induction of remission in patients…
-
The Scottish Medicines Consortium (SMC) accepts MYSODELLE® for use in NHS Scotland
in Uncategorized onFerring Pharmaceuticals Ltd, U.K. announced today that the Scottish Medicines Consortium (SMC) has accepted its new product…
-
Ferring Pharmaceuticals and Roche collaborate to develop personalised infertility treatment
in Uncategorized onFerring Pharmaceuticals and Roche have announced a collaboration to combine diagnostic testing technology from Roche with Ferring’s human cell…
-
Ferring launches Guts4life, an interactive online resource for people with inflammatory bowel disease
in Uncategorized onFerring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information…
-
New study suggests desmopressin melt improves sleep patterns and psychological functioning of bedwetting children
in Uncategorized onNew data has shown that treatment with melt-in-the-mouth desmopressin (MINIRIN® Melt)* improved sleep patterns and psychological functioning…
Uncategorized
Uncategorized